Abatacept for the Treatment of Giant Cell Arteritis
Conditions
Giant Cell Arteritis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic, Rochester, Minnesota, United States
Contact: Principal Investigator (Kenneth Warrington, MD)Hospital for Special Surgery, New York, New York, United States
Contact: Principal Investigator (Robert Spiera, MD)Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (Carol Langford, MD, MHS)University of Pennsylvania, Philadelphia, Pennsylvania, United States
Vanderbilt University, Nashville, Tennessee, United States
Contact: Principal Investigator (Kevin Byram, MD)University of British Columbia, Vancouver, British Columbia, Canada
St. Joseph's Healthcare, Hamilton, Ontario, Canada
Contact: Principal Investigator (Nader Khalidi, MD)Mount Sinai Hospital, Toronto, Ontario, Canada
Contact: Principal Investigator (Christian Pagnoux, MD, MS, MPH)Hôpital du Sacré-Coeur de Montréal Université de Montréal, Montreal, Quebec, Canada
Contact: Principal Investigator (Jean-Paul Makhzoum, MD, MSc, FRCPC, FACP)
Study leads
Peter A Merkel, MD, MPH
Principal Investigator
University of Pennsylvania
Carol A Langford, MD, MHS
Principal Investigator
The Cleveland Clinic
Jeffrey P Krischer, PhD
Principal Investigator
University of South Florida